AHR and steatosis: DLPCBs activate the aryl hydrocarbon receptor (AhR) and peroxisome proliferator-activated alpha and gamma receptors (PPARα/γ), exerting a multimodal effect on lipid accumulation and causing steatosis by disrupting hepatic lipid metabolism.